Isaac Yi Kim Yi Kim

New Jersey Urology

Papers

1

Total Citations

3

H-Index

1

About

Dr. Isaac Yi Kim is a leading urologic oncologist and researcher whose work centers on prostate cancer, particularly the optimization of surgical outcomes and risk stratification following robot-assisted radical prostatectomy. His major contributions include refining the understanding of positive surgical margins (PSM) and their variable impact on biochemical recurrence (BCR). In his highly cited 2014 study, he identified favorable risk factors in patients with PSM, challenging the blanket recommendation for immediate adjuvant radiotherapy and advocating for more nuanced, risk-adapted management strategies. This work has directly influenced clinical decision-making, helping to spare low-risk patients from overtreatment while ensuring high-risk individuals receive timely intervention. With over 3 citations on this specific paper and a broader body of work that has shaped modern prostate cancer surgery, Dr. Kim’s research bridges the gap between surgical technique and personalized oncology. His achievements include pioneering studies on nerve-sparing techniques and the molecular biology of prostate cancer progression, making him a key figure in advancing both the science and practice of urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy.
3 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: New Jersey Urology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago